Cargando…
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis
Severe COVID-19 patients show various immunological abnormalities including T-cell reduction and cytokine release syndrome, which can be fatal and is a major concern of the pandemic. However, it is poorly understood how T-cell dysregulation can contribute to the pathogenesis of severe COVID-19. Here...
Autores principales: | Kalfaoglu, Bahire, Almeida-Santos, José, Tye, Chanidapa Adele, Satou, Yorifumi, Ono, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596772/ https://www.ncbi.nlm.nih.gov/pubmed/33178221 http://dx.doi.org/10.3389/fimmu.2020.589380 |
Ejemplares similares
-
T-cell dysregulation in COVID-19
por: Kalfaoglu, Bahire, et al.
Publicado: (2021) -
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
por: Tan, Benjy J. Y., et al.
Publicado: (2022) -
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022) -
Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia
por: Veiga, Diogo F. T., et al.
Publicado: (2022) -
Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis
por: Deng, Jun, et al.
Publicado: (2018)